DOI : 10.1055/s-00000034

Klinische Pädiatrie

Issue 06/07 · Volume 228 · November 2016 DOI: 10.1055/s-006-32722


25th Annual Meeting of the working group “Experimental Neuro-Oncology”
Johannes Wesling Klinikum Minden, Germany, 29th–30th April 2016

Chair: Bernhard Erdlenbruch
Abstracts (HTML) List of Authors
E
Erdlenbruch, B: Editorial
A1
Wiese, M; Walther, N; Diederichs, C; Schill, F; Monecke, S; Downie, B; Sturm, D; Pfister, SM; Dressel, R; Johnsen, SA; Kramm, CM: The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner
A2
Bingel, C; Koeneke, E; Bittmann, A; Sill, M; Rettig, I; Ridinger, J; Fernekorn, U; Weise, F; Schober, A; Witt, O; Oehme, I: Three-dimensional tumor cell growth models in vivo drug resistance mechanisms
A3
Rashidi, A; Barcikovski, S; Jendrzej, S; Tippelt, S; Fleischhack, G; Thomas, H; Timmermann, B; Schramm, A: Enhanced radiation efficiency by gold nanoparticles after proton beam irradiation in medulloblastoma cell lines
A4
Patties, I; Frisman, M; Kendzia, E; Menzel, F; Gaunitz, F; Kortmann, RD; Glasow, A: Radiosensitizing effect of 5-aza-2'-deoxycytidin in human glioblastoma cells
A5
Bartl, J; Picard, D; Borkhardt, A; Reifenberger, G; Remke, M: Targeting the long non-coding RNA HHIP-AS1 in sonic hedgehog driven brain tumors
A6
Ecker, J; Oehme, I; Selt, F; Kool, M; Schnölzer, M; Warnken, U; Brabetz, S; Wechsler-Reya, R; Kulozik, AE; Pfister, SM; Witt, O; Milde, T: Targeting the interaction of HDAC2 and MYC in Group 3 medulloblastoma
A7
Marquardt, V; Hansen, FK; Felsberg, J; Reifenberger, G; Borkhardt, A; Kurz, T; Remke, M: High throughput screening of novel histone deacetylase inhibitors for epigenetic therapy of primary brain tumors
A8
Lacroix, J; Josupeit, R; Sorrentino, D; Geiss, C; Johann, P; Leuchs, B; Witt, O; Dinsart, C; Rommelaere, J: Parvovirus H-1 prolongs response to antineoplastc treatment with TMZ in pediatric high-grade glioma
A9
Ehrhardt, M; Frank, J; Smola, S; Graf, N: Simultaneously double infection of oncolytic viruses leads to addition of cell death induction in glioblastoma cell lines
A10
Van Gool, SW; Schirrmacher, V; Stuecker, W: Multimodal immunotherapy for DIPG: status today
A11
Garg, AD; Vandenberk, L; Koks, C; Verschuere, T; Van Gool, SW; Agostinis, P: Next-generation immunogenic dendritic cell vaccines achieve a danger signaling and T cell-driven eradication of high-grade glioma
A12
Langhans, J; Schneele, L; Trenkler, N; Karpel-Massler, G; Nonnenmacher, L; Siegelin, MD; Zhou, S; Halatsch, ME; Debatin, KM; Westhoff, MA: PI3K-mediated signalling in Glioblastoma
A13
William, D; Walther, M; Schneider, B; Classen, CF: Characteristics of Glioblastoma multiforme cancer stem-like cells
A14
Roos, WP; Eich, M; Quiros, S; Knizhnik, AV; Nikolova, T; Christmann, M; Kaina, B: Temporal and mechanistic studies on the resistance of glioma cells to temozolomide
A15
Christmann, M; Meise, R; Kaina, B; Tomicic, M: Influence of MAPK-signaling on the temozolomide and nimustine induced apoptosis in glioma cells